378 related articles for article (PubMed ID: 22879061)
1. Introduction to purinergic signalling in the brain.
Burnstock G
Adv Exp Med Biol; 2013; 986():1-12. PubMed ID: 22879061
[TBL] [Abstract][Full Text] [Related]
2. Introduction to Purinergic Signalling in the Brain.
Burnstock G
Adv Exp Med Biol; 2020; 1202():1-12. PubMed ID: 32034706
[TBL] [Abstract][Full Text] [Related]
3. Purinergic signalling: from normal behaviour to pathological brain function.
Burnstock G; Krügel U; Abbracchio MP; Illes P
Prog Neurobiol; 2011 Oct; 95(2):229-74. PubMed ID: 21907261
[TBL] [Abstract][Full Text] [Related]
4. Introduction to Purinergic Signaling.
Burnstock G
Methods Mol Biol; 2020; 2041():1-15. PubMed ID: 31646477
[TBL] [Abstract][Full Text] [Related]
5. Purinergic signalling--an overview.
Burnstock G
Novartis Found Symp; 2006; 276():26-48; discussion 48-57, 275-81. PubMed ID: 16805422
[TBL] [Abstract][Full Text] [Related]
6. An introduction to the roles of purinergic signalling in neurodegeneration, neuroprotection and neuroregeneration.
Burnstock G
Neuropharmacology; 2016 May; 104():4-17. PubMed ID: 26056033
[TBL] [Abstract][Full Text] [Related]
7. Adenosine and ATP receptors in the brain.
Burnstock G; Fredholm BB; Verkhratsky A
Curr Top Med Chem; 2011; 11(8):973-1011. PubMed ID: 21401499
[TBL] [Abstract][Full Text] [Related]
8. Introductory overview of purinergic signalling.
Burnstock G
Front Biosci (Elite Ed); 2011 Jun; 3(3):896-900. PubMed ID: 21622101
[TBL] [Abstract][Full Text] [Related]
9. Purinergic Signalling and Neurological Diseases: An Update.
Burnstock G
CNS Neurol Disord Drug Targets; 2017; 16(3):257-265. PubMed ID: 27658510
[TBL] [Abstract][Full Text] [Related]
10. Purinergic signalling: past, present and future.
Burnstock G
Braz J Med Biol Res; 2009 Jan; 42(1):3-8. PubMed ID: 18853040
[TBL] [Abstract][Full Text] [Related]
11. Purinergic signalling: Its unpopular beginning, its acceptance and its exciting future.
Burnstock G
Bioessays; 2012 Mar; 34(3):218-25. PubMed ID: 22237698
[TBL] [Abstract][Full Text] [Related]
12. Purinergic receptors in psychiatric disorders.
Krügel U
Neuropharmacology; 2016 May; 104():212-25. PubMed ID: 26518371
[TBL] [Abstract][Full Text] [Related]
13. Purinergic signaling involved in Müller cell function in the mammalian retina.
Wurm A; Pannicke T; Iandiev I; Francke M; Hollborn M; Wiedemann P; Reichenbach A; Osborne NN; Bringmann A
Prog Retin Eye Res; 2011 Sep; 30(5):324-42. PubMed ID: 21689780
[TBL] [Abstract][Full Text] [Related]
14. Membrane compartments and purinergic signalling: P2X receptors in neurodegenerative and neuroinflammatory events.
Apolloni S; Montilli C; Finocchi P; Amadio S
FEBS J; 2009 Jan; 276(2):354-64. PubMed ID: 19076216
[TBL] [Abstract][Full Text] [Related]
15. Purinergic signalling: pathophysiology and therapeutic potential.
Burnstock G
Keio J Med; 2013; 62(3):63-73. PubMed ID: 24067872
[TBL] [Abstract][Full Text] [Related]
16. Neuroglial interactions mediated by purinergic signalling in the pathophysiology of CNS disorders.
Matute C; Cavaliere F
Semin Cell Dev Biol; 2011 Apr; 22(2):252-9. PubMed ID: 21320622
[TBL] [Abstract][Full Text] [Related]
17. Purinergic signalling.
Burnstock G
Br J Pharmacol; 2006 Jan; 147 Suppl 1(Suppl 1):S172-81. PubMed ID: 16402102
[TBL] [Abstract][Full Text] [Related]
18. Neuron-glia interactions at the neuromuscular synapse.
Todd KJ; Robitaille R
Novartis Found Symp; 2006; 276():222-9; discussion 229-37, 275-81. PubMed ID: 16805433
[TBL] [Abstract][Full Text] [Related]
19. Purinergic Signalling and Endothelium.
Burnstock G
Curr Vasc Pharmacol; 2016; 14(2):130-45. PubMed ID: 26638799
[TBL] [Abstract][Full Text] [Related]
20. Purinergic Regulation of Endothelial Barrier Function.
Aslam M; Gündüz D; Troidl C; Heger J; Hamm CW; Schulz R
Int J Mol Sci; 2021 Jan; 22(3):. PubMed ID: 33530557
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
